Bivalency as a principle for proteasome inhibition

Area of Science:

• Biochemistry
• Structural Biology
• Drug Design

Background:

• The proteasome is a multicatalytic protease degrading unfolded polypeptides with low specificity, complicating inhibitor design.
• The unique topography of proteasome active sites offers opportunities for targeted inhibition strategies.

Purpose of the Study:

• To design and evaluate highly selective, multivalent inhibitors for the proteasome.
• To leverage the proteasome's active site structure for enhanced inhibitor potency.

Main Methods:

• Utilized X-ray crystallography to determine proteasome active site topography.
• Designed homo- and heterobivalent inhibitors with peptide aldehyde head groups and polyoxyethylene spacers.
• Assessed inhibitor potency through biochemical assays and X-ray analysis of proteasome/inhibitor complexes.

Main Results:

• Developed bivalent inhibitors that exploit proteasome active site separation distances.
• Polyoxyethylene spacers successfully mimicked unfolded polypeptides, facilitating access to the proteolytic chamber.
• Bivalent inhibitors demonstrated a 2-orders-of-magnitude increase in inhibitory potency compared to monovalent counterparts.

Conclusions:

• Multivalent inhibition is a viable strategy for overcoming the specificity challenges of proteasome inhibitors.
• The study validates the application of multivalency principles for inhibiting multicatalytic protease complexes.
• Structure-based design of bivalent inhibitors offers a promising approach for potent and selective proteasome targeting.